Co-trimoxazole as prophylaxis against opportunistic infections in HIV-infected Zambian children (CHAP): a double-blind randomised placebo-controlled trial.
about
Malaria attributable to the HIV-1 epidemic, sub-Saharan AfricaGlobal, regional, and national incidence and mortality for HIV, tuberculosis, and malaria during 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013.Antibiotics for preventing lower respiratory tract infections in high-risk children aged 12 years and underProphylaxis for Pneumocystis pneumonia (PCP) in non-HIV immunocompromised patientsPrevention of diarrhoea in children with HIV infection or exposure to maternal HIV infectionCotrimoxazole prophylaxis for opportunistic infections in children with HIV infectionCotrimoxazole for prophylaxis or treatment of opportunistic infections of HIV/AIDS in patients with previous history of hypersensitivity to cotrimoxazoleCotrimoxazole for prophylaxis or treatment of opportunistic infections of HIV/AIDS in patients with previous history of hypersensitivity to cotrimoxazoleCotrimoxazole prophylactic treatment prevents malaria in children in sub-Saharan Africa: systematic review and meta-analysisChildhood malnutrition: toward an understanding of infections, inflammation, and antimicrobialsEffect of cotrimoxazole prophylaxis on malaria occurrence in HIV-infected patients on antiretroviral therapy in sub-Saharan AfricaThe challenge of chronic lung disease in HIV-infected children and adolescentsImpact of antiretroviral therapy on the incidence of tuberculosis: the Brazilian experience, 1995-2001Cotrimoxazole Prophylaxis Discontinuation among Antiretroviral-Treated HIV-1-Infected Adults in Kenya: A Randomized Non-inferiority TrialCharacterization of Vaginal Escherichia coli Isolated from Pregnant Women in Two Different African SitesUptake of HIV testing and outcomes within a Community-based Therapeutic Care (CTC) programme to treat severe acute malnutrition in Malawi: a descriptive studyScientists for a better world.National policy development for cotrimoxazole prophylaxis in Malawi, Uganda and Zambia: the relationship between Context, Evidence and LinksSevere morbidity and mortality in untreated HIV-infected children in a paediatric care programme in Abidjan, Côte d'Ivoire, 2004-2009.Factors associated with coverage of cotrimoxazole prophylaxis in HIV-exposed children in South Africa.The use of interim data and Data Monitoring Committee recommendations in randomized controlled trial reports: frequency, implications and potential sources of bias.High incidence of antimicrobial resistant organisms including extended spectrum beta-lactamase producing Enterobacteriaceae and methicillin-resistant Staphylococcus aureus in nasopharyngeal and blood isolates of HIV-infected children from Cape Town,18-month occurrence of severe events among early diagnosed HIV-infected children before antiretroviral therapy in Abidjan, Côte d'Ivoire: a cohort study.Improving outcomes in infants of HIV-infected women in a developing country settingEFFECT OF TRIMETHOPRIM-SULFAMETHOXAZOLE PROPHYLAXIS ON FAECAL CARRIAGE RATES OF RESISTANT ISOLATES OF ESCHERICHIA COLI IN HIV-INFECTED ADULT PATIENTS IN LAGOSGuidelines for the Prevention and Treatment of Opportunistic Infections among HIV-exposed and HIV-infected children: recommendations from CDC, the National Institutes of Health, the HIV Medicine Association of the Infectious Diseases Society of AmerGrowth among HIV-infected children receiving antiretroviral therapy in Dar es Salaam, Tanzania.Treatment and disease progression in a birth cohort of vertically HIV-1 infected children in UkraineImplementation of co-trimoxazole prophylaxis and isoniazid preventive therapy for people living with HIV.Tuberculosis and pneumonia in HIV-infected children: an overviewPlasmodium falciparum dihydrofolate reductase and dihyropteroate synthase mutations and the use of trimethoprim-sulfamethoxazole prophylaxis among persons infected with human immunodeficiency virusHIV-exposed infants: rethinking care for a lifelong condition.Operational research in Malawi: making a difference with cotrimoxazole preventive therapy in patients with tuberculosis and HIV.Beyond early infant diagnosis: case finding strategies for identification of HIV-infected infants and children.Water filter provision and home-based filter reinforcement reduce diarrhea in Kenyan HIV-infected adults and their household members.Impact of HIV/Aids on Child Mortality before the Highly Active Antiretroviral Therapy Era: A Study in Pointe-Noire, Republic of Congo.Impact of cotrimoxazole on carriage and antibiotic resistance of Streptococcus pneumoniae and Haemophilus influenzae in HIV-infected children in ZambiaRandomized controlled trials of HIV/AIDS prevention and treatment in Africa: results from the Cochrane HIV/AIDS Specialized Register.Post-discharge mortality in children with severe malnutrition and pneumonia in Bangladesh.Guidelines for the prevention and treatment of opportunistic infections in HIV-exposed and HIV-infected children: recommendations from the National Institutes of Health, Centers for Disease Control and Prevention, the HIV Medicine Association of the
P2860
Q21032444-9EE1F92A-472A-48E4-A8B3-3512B705EECBQ21034169-42D82DB2-4E3D-4435-9D91-AC1DD88ADA54Q24186994-1651B436-2FD8-4ADF-86C9-A6143CFCD3D1Q24193204-CE76C2AD-B536-4A0C-80A6-98963584FD3CQ24234778-BAB99166-74F0-4990-B599-FB2F29876E60Q24244620-A8497014-65D4-4BC4-ABA6-A0613AB7E229Q24245223-F0B4697A-902F-4A1A-9329-BA5E5CF1F989Q24245408-CB7A30F0-A6C5-40B8-9CEC-903BA841BE68Q27009235-D214E6E5-A20B-4625-975B-58717DFE1340Q27024511-28C2DB71-E688-47B2-ADC3-DAEF1B98A751Q28084902-3D814BEF-C737-405C-9D72-AA81B73AF1DCQ28384616-75BE82F3-C56E-4DD9-AC8F-9BA954CA0FF2Q28469286-78139F1C-C81B-411F-A2D9-294BFEC701EFQ28552031-63826D45-76DA-4904-A6C0-CC09AAE7C118Q28552421-86826579-AEB2-46A8-A5A9-22052C16D5E5Q30397919-88737441-8B94-4727-8D38-D7912C6F0AA6Q30399158-8E2C6E0F-D444-4BC3-BAA1-E13E36853BA3Q30501533-94E9F4A7-E5FA-4F3D-99F0-B780BE918782Q31020587-FE58A699-26C8-4683-8A67-401925E5D36FQ31116941-F39A3F58-9463-4BF1-BA01-7CB4D0223D2CQ31150630-6C8E811E-F327-4F7C-A910-E061785AB6ABQ33326481-5C526CBF-A594-443A-9031-1DD3F2403647Q33336235-9458FD8D-2CAB-45D4-81AE-DC2BA862D06FQ33384449-C17E5B5E-2830-4D83-AA0E-FBD53A246399Q33623400-394B42B1-18A3-4309-83D3-55BF749E942EQ33650105-100F7723-90ED-4FC3-8027-1A6EAE0ECEF5Q33695680-D9BB3529-17B7-4AC7-9C3D-D90DAD940AC0Q33752198-B45E244D-6080-4031-A554-F699C1A1E9E1Q33793347-6644BFE3-B107-40B3-B6F0-74E81A0A16B4Q33801297-A7D94E5C-CE5D-4A9A-8D31-28042D8DEBA5Q33817605-39260F66-EBBB-4174-A4D9-EA80B6BE2F20Q33871174-DB28E479-032E-4E02-A2B8-304313FA27E3Q33973050-7BB3C709-8134-42C6-A36D-B0F021B54464Q34006876-CBC986CB-AD56-4E10-9438-4EAC04D92111Q34015894-52B43F0B-E697-4181-8FA4-AFCC41187479Q34106178-6F10FF47-286A-44BB-950E-06EAE8540F59Q34108680-6EC07666-B575-4E48-9994-C41486780BF9Q34110332-BBF39812-DEB1-4EA4-9F18-8E2FF637CF77Q34203260-543E3F72-F6D4-421B-935B-7A388C04368BQ34212799-AC9348DC-DEC4-4065-B78E-9C26D4C9A660
P2860
Co-trimoxazole as prophylaxis against opportunistic infections in HIV-infected Zambian children (CHAP): a double-blind randomised placebo-controlled trial.
description
2004 nî lūn-bûn
@nan
2004 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Co-trimoxazole as prophylaxis ...... ised placebo-controlled trial.
@ast
Co-trimoxazole as prophylaxis ...... ised placebo-controlled trial.
@en
Co-trimoxazole as prophylaxis ...... HIV-infected Zambian children
@nl
type
label
Co-trimoxazole as prophylaxis ...... ised placebo-controlled trial.
@ast
Co-trimoxazole as prophylaxis ...... ised placebo-controlled trial.
@en
Co-trimoxazole as prophylaxis ...... HIV-infected Zambian children
@nl
prefLabel
Co-trimoxazole as prophylaxis ...... ised placebo-controlled trial.
@ast
Co-trimoxazole as prophylaxis ...... ised placebo-controlled trial.
@en
Co-trimoxazole as prophylaxis ...... HIV-infected Zambian children
@nl
P2093
P1433
P1476
Co-trimoxazole as prophylaxis ...... ised placebo-controlled trial.
@en
P2093
A S Walker
CHAP trial team
F Sinyinza
K Lishimpi
L Farrelly
N Kaganson
P304
P356
10.1016/S0140-6736(04)17442-4
P407
P577
2004-11-01T00:00:00Z